Dowling & Yahnke LLC Fortress Biotech, Inc. Transaction History

Dowling & Yahnke LLC

  • $215 Million
  • Q3 2022

A detailed history of Dowling & Yahnke LLC transactions in Fortress Biotech, Inc. stock. As of the latest transaction made, Dowling & Yahnke LLC holds 20,000 shares of FBIO stock, worth $51,200. This represents 0.01% of its overall portfolio holdings.

Number of Shares
20,000
Previous 20,000 -0.0%
Holding current value
$51,200
Previous $17,000 -0.0%
% of portfolio
0.01%
Previous 0.0%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2019

Apr 30, 2019
BUY
$0.94 - $2.47 $18,800 - $49,400
20,000 New
20,000 $36,000

Others Institutions Holding FBIO

# of Institutions
5
Shares Held
862K
Call Options Held
0
Put Options Held
0
View Full List

About Fortress Biotech, Inc.

FBIO Quotes by TradingView
  • Ticker FBIO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 107,735,000
  • Market Cap $276M
  • Description
  • Fortress Biotech, Inc., a biopharmaceutical company, develops and commercializes pharmaceutical and biotechnology products. The company markets dermatology products, such as Ximino capsules to treat only inflammatory lesions of non-nodular moderate to severe acne vulgaris; Targadox for severe acne; Exelderm cream for ringworm and jock itch sympt...
More about FBIO
Track This Portfolio

Track Dowling & Yahnke LLC Portfolio

Follow Dowling & Yahnke LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Dowling & Yahnke LLC, based on Form 13F filings with the SEC.

News

Stay updated on Dowling & Yahnke LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email